Skip to main content
. 2021 Aug 24;10(17):3777. doi: 10.3390/jcm10173777

Table 6.

NOD2 gene haplotypes and association analysis.

Name * Alleles/Haplotypes Frequency ** Disease Entity
CD vs. UC
Crohn’s Disease Ulcerative Colitis
Predisposition to Late-Onset Form Predisposition to Early-Onset Form Sex
(Women vs. Men)
Predisposition to Late-Onset Form Predisposition to Early-Onset Form Sex
(Women vs. Men)
p.P268S p.R702W p.G908R c.2798
+158C>T
1007fs Controls CD UC OR
(95% CI)
p-Value OR
(95% CI)
p-Value OR
(95% CI)
p-Value OR
(95% CI)
p-Value OR
(95% CI)
p-Value OR
(95% CI)
p-Value OR
(95% CI)
p-Value
A C C G C wt. 39.5% 50.3% 72.0% 0.40
(0.32–0.51)
< 0.001 1.77
(1.27–2.48)
< 0.001 1.26
(0.87–1.82)
0.241 0.61
(0.35–1.08)
0.091 3.40
(2.43–4.78)
< 0.001 2.67
(1.77–4.01)
< 0.001 1.17
(0.66–2.07)
0.598
- C C C C wt. 25.4% n.o. n.o. n.a. - 0.01
(0.00–0.12)
< 0.001 0.03
(0.01–0.16)
< 0.001 n.a. - 0.03
(0.01–0.11)
< 0.001 0.02
(0.01–0.17)
< 0.001 n.a. -
H T C G C wt. 8.2% 9.7% 7.2% 1.24
(0.81–1.88
0.323 1.35
(0.77–2.35)
0.297 1.44
(0.80–2.59)
0.195 0.75
(0.29–1.96)
0.561 1.04
(0.59–1.85)
0.883 1.74
(0.95–3.19)
0.074 0.67
(0.25–1.84)
0.440
D T C C C wt. 5.2% 3.1% 1.7% 1.88
(0.90–3.93)
0.095 0.10
(0.01–0.72)
0.023 0.50
(0.17–1.46)
0.206 7.69
(0.39–150.88)
0.179 0.34
(0.12–1.00)
0.051 0.15
(0.02–1.11)
0.063 1.49
(0.24–9.07)
0.668
T C C T wt. 4.3% n.o. n.o. n.a. - 0.12
(0.02–0.88)
0.037 0.07
(0.01–1.19)
0.066 n.a. 0.10
(0.01–0.77)
0.027 0.09
(0.01–1.46)
0.090 n.a. -
G T C G T wt. 4.2% 9.0% 6.8% 1.28
(0.82–1.99)
0.283 1.89
(0.95–3.78)
0.071 2.97
(1.50–5.88)
0.002 3.18
(0.98–10.37)
0.055 2.00
(1.04–3.87)
0.039 2.61
(1.26–5.41)
0.010 1.51
(0.56–4.05)
0.412
E T C G T insC 3.5% 13.3% 3.3% 4.13
(2.55–6.71)
< 0.001 5.09
(2.59–9.97)
< 0.001 4.62
(2.26–9.47)
< 0.001 1.28
(0.56–2.94)
0.555 0.76
(0.27–2.13)
0.598 1.92
(0.76–4.85)
0.170 0.65
(0.11–3.96)
0.639
- T C C T insC 2.1% n.o. n.o. n.a. - 0.11
(0.01–1.95)
0.134 0.61
(0.13–2.82)
0.527 n.a. - 0.10
(0.01–1.70)
0.111 0.10
(0.01–3.00)
0.229 n.a. -
- C C G C insC 1.9% 1.6% 2.0% 0.70
(0.28–1.75)
0.447 1.08
(0.33–3.56)
0.897 1.02
(0.27–3.82)
0.977 0.53
(0.05–5.91)
0.603 2.17
(0.85–5.55)
0.105 0.41
(0.05–3.29)
0.404 1.24
(0.32–4.74)
0.755
- C C C C insC 1.7% n.o. n.o. n.a. - 0.14
(0.01–2.46)
0.179 0.18
(0.01–3.10)
0.274 n.a. - 0.12
(0.01–2.15)
0.151 0.22
(0.01–3.78)
0.295 n.a. -
- C C C T wt. 1.4% n.o. n.o. n.a. - 0.16
(0.01–2.82)
0.211 0.20
(0.01–3.55)
0.274 n.a. - 0.14
(0.01-2.46)
0.179 0.25
(0.01–4.34)
0.339 n.a. -
- T C G C insC n.o. 2.8% 1.9% 2.47
(1.08–5.64)
0.033 23.01
(2.90–182.91)
0.003 n.a. - 1.08
(0.30–3.85)
0.907 n.a. - 3.73
(1.06–13.08)
0.040 n.a. -
B T T G T wt. n.o. 5.1% 1.6% 2.90
(1.40–6.00)
0.004 17.71
(2.16–144.90)
0.007 29.36
(3.69–233.68)
0.001 3.34
(0.66–16.98)
0.146 n.a. - 1.81
(045–7.35)
0.405 n.a. -
- C C G T wt. n.o. 2.4% n.o. 1.33
(0.53–3.34
0.537 n.a. - 12.93
(2.72–61.58)
0.001 n.a. - n.a. - n.a. - n.a. -

Statistically significant results and minor alleles are marked in bold; wt.: wild type allele (in this case: allele without insertion); *: according to Tukel et al.; **: haplotype frequencies evaluated and rounded using Haploview; n.a.: not analyzed; n.o.: not observed.